🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, phase Ib study. In this trial, patients w...
Status
Completed
Location
Complejo Hospitalario Universitario A Coruña
Start Date
2014-05
Trial ID
NCT02027376
Background: Oral hedgehog inhibitors vismodegib and sonidegib have been use...
Status
Recruiting
Location
Radboudumc
Start Date
2021-11-01
Trial ID
NCT05463757
Treatments Being Tested
The purpose of this study is to test the safety of study drug LDE225 at dif...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2012-04
Trial ID
NCT01579929
Treatments Being Tested
The purpose of this study is to test the safety and determine the maximum s...
Status
Completed
Location
UCSD Moores Cancer Center
Start Date
2014-07
Trial ID
NCT02151864
Treatments Being Tested
This is a multi center, open-label study to evaluate the drug-drug interact...
Status
Completed
Location
City of Hope National Medical Center Oncology
Start Date
2013-04
Trial ID
NCT01769768
This is a Phase IV, single arm, multicenter study designed to evaluate the ...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-06-21
Trial ID
NCT06880848
Treatments Being Tested
This pilot trial studies how well sonidegib and buparlisib work in treating...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2015-02
Trial ID
NCT02303041
Treatments Being Tested
This is a prospective single-center, open label, pilot study to investigate...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2012-02
Trial ID
NCT01529450
Treatments Being Tested
In this study, patients with BCC will be given neoadjuvant treatment with a...
Status
Completed
Location
Melanoma Institute Australia
Start Date
2019-07-23
Trial ID
NCT03534947
Treatments Being Tested
This was a phase II, double-blind, randomized, proof-of-concept, dose-rangi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01350115